Medicare Benefits Schedule - Item 73343

Detection of 17p chromosomal deletions by fluorescence in situ hybridisation or genome wide micro‑array, in a patient with chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood, bone marrow or lymph node sample, requested by a specialist or consultant physician

For any particular patient:

(a) at initial diagnosis; or

(b) at disease relapse; or

(c) on disease progression;

but only where initiation of, or change in, therapy is anticipated

Fee: $589.90 Benefit: 75% = $442.45 85% = $501.45

• Previous - Item 73342
• Next - Item 73344